Early-onset pancreatic cancer patients benefit more from neoadjuvant chemotherapy and surgery
Background and objectives The incidence of early-onset pancreatic cancer (EOPC) is rising, yet optimal treatment strategies remain unclear.…
Targeting lactate metabolism offers new avenues for cancer treatment
Lactic acid (LA) has transitioned from being perceived as a mere glycolytic waste product to a pivotal regulator…
‘Two-in-one’ RNA molecule can simultaneously turn off two difficult-to-target cancer-related genes
University of North Carolina Lineberger Comprehensive Cancer Center researchers have developed a “two-in-one” molecule that can simultaneously turn…
Clinical insights from lymphoid structures
Sponsored Content by TissueGnosticsReviewed by Maria OsipovaJul 31 2025 In this interview, we spoke with Associate Professor Diana…
NKAPL identified as a tumor suppressor and therapeutic target in NSCLC
Non-small cell lung cancer (NSCLC) accounts for over 80% of lung cancer cases and is often diagnosed at…
Senescent macrophages emerge as key drivers of tumor progression
Macrophages are versatile immune cells, tasked with cleaning up pathogens and maintaining tissue health. But within the tumor…
Blocking nutrient scavenging weakens pancreatic tumor defenses
Cancer cells and tumors do not exist in a vacuum. Far from the isolation and self-sufficiency of the…
New therapeutic approach targets undruggable protein driving aggressive breast cancer
In a major stride toward tackling aggressive breast cancer, researchers from The Hebrew University of Jerusalem have developed…
Researchers unveil drug complex that makes cancer cells self-report to immune system
Two junior research groups at Ruhr University Bochum, Germany, have developed a drug complex that kills cancer cells…